Central stimulants act on the central nervous system to enhance patients' alertness, attention, and alleviate fatigue. Protheragen provides high-purity, high-bioavailability central stimulant APIs, playing a crucial role in the treatment of conditions such as attention-deficit/hyperactivity disorder (ADHD), narcolepsy, and obesity.

At Protheragen, we strictly adhere to cGMP, FDA, and other regulatory standards to ensure product safety and efficacy. Our full range of central stimulant APIs includes both classical and novel derivative products, and we provide customized solutions for global customers' research and production needs.